Delivery Order SPE2DB20D3103-SPE2DB23FN2F2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $6,398.96, is a firm fixed-price delivery order for the supply of Mupirocin 2% Cream in 15-gram units. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which serves as a primary vehicle for the company to...
- This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of Mupirocin 2% Ointment. The $1,032.84 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This federal contract award, valued at $2,679.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Mupirocin 2% Cream, a pharmaceutical product, to support military treatment facilities and other government healthcare programs. This award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,223.45 firm fixed-price delivery order is for the supply of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award, valued at $5,671.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Mupirocin 2% Cream, a topical antibiotic medication, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a significant...
- This federal contract award, valued at $1,704.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% Cream, a topical antibiotic medication, with an ultimate completion date of April 11, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mupirocin 2% Cream. The contract is a Delivery Order with a Firm Fixed Price of $10,292.51 and a performance period through May 7, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- This federal contract award is a delivery order valued at $2,223.27 from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,188,685 units of Mupirocin 2% Cream, 15 gm, with a performance period ending on May 9, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Mupirocin 2% Cream in 15 gram units, with a ceiling value of $3,226.55 and a completion date of January 12, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award, valued at $5,052.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% Cream, a prescription pharmaceutical product. It is a Firm Fixed Price Delivery Order with an ultimate completion date of October 25, 2023. The contract was awarded on October 24, 2023 and was not set aside for any specific business category....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN2F2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by parent company Cencora, Inc. The $2,152.21 delivery order is for the supply of Mupirocin 2% Cream, a topical antibiotic medication, to support military healthcare programs. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense worldwide. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen has also been awarded a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contract awards demonstrate Amerisourcebergen's significant role as a critical supplier of essential pharmaceutical and medical products to various federal government agencies, particularly the DLA and military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 4/27/23 |